Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Expert Opinion on Drug Safety|January 12, 2012
Pharmaceutical industry perspective on risk evaluation and mitigation strategies: manufacturer take heedSusan Nicholson, Janet Peterson, Behin YektashenasJournal of the Academy of Nutrition and Dietetics|June 23, 2022
Academy of Nutrition and Dietetics: Revised 2022 Standards of Practice and Standards of Professional Performance for Registered Dietitian Nutritionists (Competent, Proficient, and Expert) in Adult Weight ManagementColleen Tewksbury, Robin Nwankwo, Janet PetersonCurrent Medical Research and Opinion|February 7, 2009
Levofloxacin for the treatment of pneumonia caused by Streptococcus pneumoniae including multidrug-resistant strains: pooled analysisJanet Peterson, Behin Yektashenas, Alan C FisherDrug Safety|December 17, 2011
Risk evaluation and mitigation strategies (REMS): educating the prescriberSusan C Nicholson, Janet Peterson, Behin YektashenasCurrent Medical Research and Opinion|May 8, 2009
Levofloxacin versus azithromycin on the oropharyngeal carriage and selection of antibacterial- resistant streptococci in the microflora of healthy adultsCarl Erik Nord, Janet Peterson, Mary Ambruzs, et al.Clinical Therapeutics|November 29, 2007
Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006Janet Peterson, Simrati Kaul, Mohammed Khashab, et al.Urology|February 5, 2008
A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritisJanet Peterson, Simrati Kaul, Mohammed Khashab, et al.Journal of Clinical Pharmacology|October 22, 2005
Pharmacokinetics of pradefovir and PMEA in healthy volunteers after oral dosing of pradefovirChin-chung Lin, Christine Xu, Alice Teng, et al.Current Medical Research and Opinion|April 17, 2010
Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitisMargaret Paglia, Janet Peterson, Alan C Fisher, et al.Respiratory Care|January 12, 2013
Comparison of the bacterial etiology of early-onset and late-onset ventilator-associated pneumonia in subjects enrolled in 2 large clinical studiesMarcos I Restrepo, Janet Peterson, Juan F Fernandez, et al.Pageof 2